Search Results - "Scheithauer W"

Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer - A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial.

Authors: Heinrich K Stintzing S Weikersthal LFV et al.

Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jan; Vol. 232, pp. 116133. Date of Electronic Publication: 2025 Nov 22.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.

Authors: Salgado, Mercedes de la Camara-Gómez, Juan García-Escobar, Ignacio et al.

Source: BMC Cancer. 11/17/2025, Vol. 25 Issue 1, p1-10. 10p.

Cardiovascular Risk in Pancreatic Cancer: A Meta-Analysis of 197 Studies.

Authors: Németh, Jázmin Lee, Jimin Eperjesi, Orsolya et al.

Source: Cancers. Apr2026, Vol. 18 Issue 7, p1108. 14p.

Chemotherapeutic Loading and Delivery of Patient-Derived Extracellular Vesicles Are Influenced by Colorectal Cancer Disease Stage and Protein Corona.

Authors: Saud, Otman Blidi, Dallal Hayes, Emily et al.

Source: Pharmaceutics. Jun2026, Vol. 18 Issue 6, p740. 20p.

Molecular Characterization of Small Extracellular Vesicles in Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy Followed by Stereotactic Body Radiation.

Authors: Paluri, Ravi Kumar Kumar, Ashish Su, Yixin et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1704. 12p.

Fibrinogen and colorectal cancer: A study of the Chinese population.

Authors: Wang, Jinfeng Li, Jingjing Huo, Jing et al.

Source: PLoS ONE. 5/7/2025, Vol. 20 Issue 5, p1-11. 11p.

Impact of biliary drainage for unresectable pancreatic cancer treated with nanoliposomal irinotecan with fluorouracil and folinic acid: retrospective results from the NAPOLEON-2 study.

Authors: Nishikawa, Kazuo Otsuka, Taiga Shimokawa, Mototsugu et al.

Source: BMC Cancer. 10/21/2025, Vol. 25 Issue 1, p1-10. 10p.

Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study.

Authors: Ishii, Masatsugu Itano, Osamu Iwamoto, Hideki et al.

Source: PLoS ONE. 11/6/2025, Vol. 20 Issue 11, p1-12. 12p.

Author Index for Volume 99.

Source: British Journal of Cancer. 12/16/2008, Vol. 99 Issue 12, p2101-2109. 9p.

Author Index for Volume 88.

Source: British Journal of Cancer. 12/15/2003, Vol. 89 Issue 12, p2342-2349. 8p.

CEA and CA-19-9 Dynamics Associate with Survival in Regorafenib-Treated Metastatic Colorectal Cancer: A Real-World Analysis.

Authors: Yalçıner, Merih Örüncü, Mehmet Berk Kayaalp, Mehmet et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 7, p2599. 15p.

Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapy.

Authors: Yang, Mingli Schell, Michael J. Salk, Jesse J. et al.

Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-19. 19p.

Oncologic and Surgical Outcomes After Short-Course Neoadjuvant CAPOX Plus Bevacizumab in High-Risk Colorectal Liver Metastases.

Authors: Dong, Yawen Tschoegl, Madita Lehner, Florian et al.

Source: Cancers. Feb2026, Vol. 18 Issue 3, p521. 18p.

Genetic Susceptibility to Helicobacter pylori Infection and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomisation Study.

Authors: Yang, Nien-Yu Ke, Te-Min Huang, Yicong et al.

Source: Life (2075-1729). Feb2026, Vol. 16 Issue 2, p284. 14p.

A Co-Design Study Developing an Early Prototype Intervention to Support Oral Anticancer Medication Use in Breast Cancer.

Authors: Seo, Yejin Hudmon, Karen Suchanek Weddle, Kellie Jones et al.

Source: Patient Preference & Adherence. Feb2026, Vol. 20, p1-12. 12p.

Refining Outcomes in Technically Resectable Colorectal Liver Metastases: A Simplified Risk Model and the Role of Preoperative Chemotherapy.

Authors: Kanesada, Kou Nakajima, Masao Ioka, Tatsuya et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p227. 16p.

Fine-Tuning Side Chain Substitutions: Impacts on the Lipophilicity–Solubility–Permeability Interplay in Macrocyclic Peptides.

Authors: Deng, Yangping Bian, Hengwei Li, Hongbo et al.

Source: Marine Drugs. Jan2026, Vol. 24 Issue 1, p13. 18p.

Niclosamide-Loaded Polyanhydride Nanoparticles to Combat Gemcitabine Resistance in Pancreatic Cancer.

Authors: White, Brianna M. Gunda, Venugopal Nethi, Susheel Kumar et al.

Source: Regenerative Engineering & Translational Medicine. Dec2025, Vol. 11 Issue 4, p949-962. 14p.

Genetic, Epidemiological, Clinical, and Therapeutic Trajectories in Colon and Rectal Cancers.

Authors: Capuozzo, Maurizio Picone, Carmine Sabbatino, Francesco et al.

Source: Cancers. Nov2025, Vol. 17 Issue 21, p3438. 44p.

Prolonged Survival Outcome in a Patient with Refractory Metastatic Colorectal Cancer Treated with Regorafenib Plus 5-Fluorouracil: A Case Report and Literature Review.

Authors: Esmail, Abdullah Khasawneh, Bayan Al-Najjar, Ebtesam et al.

Source: Reports (MDPI AG). Jun2025, Vol. 8 Issue 2, p59-N.PAG. 10p.